Form 8-K - Current report:
SEC Accession No. 0001104659-20-033682
Filing Date
2020-03-16
Accepted
2020-03-16 08:00:28
Documents
1
Period of Report
2020-03-11
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2012688-1_8k.htm 8-K 14985
  Complete submission text file 0001104659-20-033682.txt   16121
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38129 | Film No.: 20715324
SIC: 2834 Pharmaceutical Preparations